Orchid Pharma’s wholly owned subsidiary -- Orchid Bio-Pharma has entered into a Memorandum of Understanding (MoU) with an overseas technology provider for in-licensing 7ACA technology.
Earlier, Orchid Bio-Pharma had received approval to manufacture the product ‘7 ACA’ with a committed capacity of 1000 Metric Tonne Per Annum. This approval will help the company in backward integration, reduce dependency on sourcing from China and aid in improving margins.
Orchid Pharma, established as an export-oriented unit (EOU), is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1690.00 |
| Dr. Reddys Lab | 1221.80 |
| Cipla | 1235.50 |
| Zydus Lifesciences | 941.35 |
| Lupin | 2322.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: